Adherence, safety, efficacy – three pillars of hypertension treatment with fixed dose combinations

Objective. ToGlobally more than 1.4 billion people have hypertension, of whom less than 15% have their blood pressure appropriately controlled (BP), and that is the leading cause of death globally. In low- and middle-income countries, more than 70% of the treated patients have uncontrolled hypertension. One of the major reasons for poor control is reliable patient adherence to treatment. fixed-dose combinations, which incorporate two antihypertensive drugs or more can improve control rates BP without increasing the risk of adverse events, and can thereby prevent complications of uncontrolled hypertension. The advantages of fixed combinations from Canonpharma Production are proven bioequivalence to reference drugs, good tolerability, ease of use and lower cost compared to original drugs. fixed combinations from Canonpharma Production are represented by several two- and three-component combinations of antihypertensive drugs in various dosages, which help physician to prescribe and escalate antihypertensive therapy.